Lifesciences Business Development Specialist (Hyderabad)

Cheiron is a Stanford-based AI company building the AI-native operating system for drug development.

Biopharma knowledge work is structurally fragmented. Critical decisions depend on stitching together evidence across literature, clinical trials, regulatory precedent, and patentsspread across disconnected systems. Cheiron replaces this paradigm with a unified intelligence layer: our proprietary Lifesciences Knowledge Graph (LKG), which integrates and structures these data sources into a single, continuously evolving system of record.

On top of this foundation, Cheiron deploys workflow-native AI agents that execute real-world R&D, clinical, and regulatory tasks end-to-endwith full traceability and scientific rigor.

Since launching in 2024, Cheiron has achieved rapid global adoption. In Korea, we reached 22% of the biopharma knowledge workforce across 200+ organizations within six months. In the United States, within two months of launch, we onboarded thousands of professionals across hundreds of biopharma companies, driven by strong organic demand.

Cheiron is proudly pre-VC, backed by a $6M+ angel round from globally recognized investors, including leaders from the SK and Samsung families and co-authors of Attention Is All You Need.

As we scale our U.S. presence, we are expanding a deeply interdisciplinary team at the intersection of AI, life sciences, and real-world drug development workflows.

We are seeking a Business Development Specialist to define how asset evaluation, deal-making, and strategic partnering workflows are executed within Cheiron.

This role is designed for individuals experienced in licensing, partnerships, and asset evaluation who can formalize decision-making processes into AI-native workflows.

Apply Cheiron to BD workflows:

• Asset scouting and landscape analysis
• Target/indication prioritization
• Deal evaluation and benchmarking
• Competitive and strategic positioning

Evaluate AI outputs for:

• Strategic relevance and completeness
• Commercial and clinical viability signals
• Accuracy of competitive landscape interpretation

Structure frameworks for:

• Asset evaluation criteria (clinical, regulatory, commercial)
• Deal comparables and benchmarking logic

Collaborate with product/AI teams to:

• Build agents for opportunity identification and evaluation
• Integrate scientific and commercial reasoning

Contribute to high-quality datasets for BD decision-making

This role is intended for professionals involved in strategic decision-making around asset evaluation, partnerships, and licensing within the biopharma industry.

• Business Development or Licensing professionals in pharma/biotech
• Individuals with experience in asset evaluation, deal structuring, and partnership strategy
• Strategy, corporate development, or commercial professionals working on pipeline and portfolio decisions
• Consultants or analysts focused on biotech landscape analysis and opportunity assessment
  

• Experience in Business Development, Licensing, or Strategy in pharma/biotech
• Strong understanding of drug development and commercial drivers
• Ability to evaluate assets across scientific and market dimensions
  

This full-time role offers $200k - $250k in total compensation, including performance-based bonus. Compensation is determined by experience, expertise, and role alignment. Benefits include competitive healthcare, equity participation, and the opportunity to work closely with a world-class interdisciplinary team.